Related Experiment Video
Updated: Dec 17, 2025
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.8K
Pharmacogenomics and Personalized Medicine.
Erika Cecchin1, Gabriele Stocco2
1Experimental and Clinical Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Genes
|June 26, 2020
Summary
Pharmacogenomics, a key to precision medicine, faces slow clinical adoption despite published guidelines. New research explores immune system genetics and rare variants to improve drug efficacy and safety.
Area of Science:
- Pharmacogenomics and Precision Medicine
- Genetics and Drug Metabolism
- Clinical Pharmacology
Background:
- Pharmacogenomics aims to personalize drug therapy based on genetic profiles, but its clinical integration remains limited.
- International guidelines exist, yet practical implementation faces significant barriers.
- Current pharmacogenetic markers explain only a fraction of inter-individual variability in drug response.
Discussion:
- Overcoming barriers to pharmacogenomic implementation requires coordinated international efforts.
- Investigating the genetic basis of the immune system's role in drug response is crucial.
- Exploring the impact of rare genetic variants is essential for a comprehensive understanding of drug metabolism variability.
Key Insights:
- Existing pharmacogenetic guidelines have not translated into widespread clinical practice.
- New research directions include studying immune system genetics and rare genetic variants.
- Rare variants may significantly contribute to inter-individual differences in drug metabolism and efficacy.
Outlook:
- Future efforts should focus on developing tools and infrastructure to support clinical pharmacogenomics.
- Identifying novel pharmacogenomic markers will enhance drug efficacy and patient safety.
- Integrating insights from rare genetic variants will advance personalized medicine approaches.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
01:24Dosage Regimen: Individualization
109
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
109
01:12Analysis of Population Pharmacokinetic Data
597
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
597
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
88
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
88
01:21Pharmacodynamics: Overview and Principles
2.6K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.6K
01:28Biopharmaceutics and Pharmacokinetics: Overview
3.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.1K